Dr. Sandra Eagle outlines how due diligence has evolved from a discrete standalone technical assessment, to now being an integrated part of the holistic development continuum of an asset.
This article is reproduced with permission from European Biopharmaceutical Review, April 2023, pages 81-82. © Samedan Ltd
Read article